Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Fundamental & Clinical Pharmacology|February 24, 2026
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024Cécile Chevallier, Anne Batisse, Emilie Monzon, et al.
Harm Reduction Journal|October 28, 2022
Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)Benjamin Rolland, Caroline Lions, Vincent Di Beo, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|March 1, 2022
Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F)Noémie Delage, Nathalie Cantagrel, Jessica Delorme, et al.
Frontiers in Psychiatry|May 13, 2021
Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained PatientsJessica Delorme, Lucie Pennel, Georges Brousse, et al.
Joint Bone Spine|July 13, 2020
Opioid epidemic: Does rheumatological practice favors risk for patients? National survey on rheumatologists' opioid prescriptions and compliance to guidelines for strong opioid prescriptionAnne-Priscille Trouvin, Chouki Chenaf, Marie Riquelme, et al.
European Journal of Clinical Pharmacology|December 25, 2014
Heart failure prognosis and management in over-80-year-old patients: data from a French national observational retrospective cohortCharles Vorilhon, Chouki Chenaf, Aurélien Mulliez, et al.
British Journal of Clinical Pharmacology|August 6, 2020
Trajectories of antidepressant drugs during pregnancy: A cohort study from a community-based sampleAurélie Cabaillot, Alexandra Bourset, Aurélien Mulliez, et al.
Cancer Chemotherapy and Pharmacology|November 6, 2023
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?Angeline Ginzac, Emilie Thivat, Caroline Petorin, et al.
Addiction (Abingdon, England)|October 10, 2019
Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study)Tangui Barré, Fabienne Marcellin, Vincent Di Beo, et al.
The International Journal on Drug Policy|May 27, 2019
Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO projectTeresa Rojas Rojas, Vincent Di Beo, Jessica Delorme, et al.
Pageof 10